Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Feb 26, 2022

When a patient does not respond to an SSRI trial, what is the best strategy—increase the dose, augment with another agent, or switch to another SSRI? In this interview, Dr. Hudak discusses dosing strategies and the treatment of patients with OCD and comorbid psychiatric conditions. 

Guest: Robert Hudak,...

Feb 21, 2022

This episode discusses lithium augmentation for psychotic depression, including evidence from different case series and open-label studies. It also addresses some clinical strategies for lithium augmentation. 

Faculty: David Osser, M.D. 
Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.

Feb 16, 2022

Which medications can be used for acute and chronic agitation in dementia?
For acute agitation, you might consider the use of haloperidol. For chronic agitation, you could consider citalopram: Its efficacy has been found to be equal to that of antipsychotics in randomized trials.

Faculty: Jim Phelps, M.D.
Hosts: Jessica...

Feb 11, 2022

This episode discusses how to choose an antipsychotic for psychotic depression combination therapy. It also reviews the efficacy and side effects of first- and second-generation antipsychotics and the evidence of SGAs for psychotic depression. 

Faculty: David Osser, M.D. 
Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.

Feb 6, 2022

COVID-19 infection is associated with new-onset neurological illness but at relatively low absolute rates. On the other hand, rates for new-onset anxiety and mood disorders can be higher, at 7% and 8%, respectively. 

Faculty: Jim Phelps, M.D. 
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.